Hakan KALAYCI
(Başkent Üniversitesi, Tıp Fakültesi Kadın Hastalıkları ve Doğum Ana Bilim Dalı, Adana Uygulama ve Araştırma Hastanesi, Adana, Türkiye)
Gülşen Doğan DURDAĞ
(Başkent Üniversitesi, Tıp Fakültesi Kadın Hastalıkları ve Doğum Ana Bilim Dalı, Adana Uygulama ve Araştırma Hastanesi, Adana, Türkiye)
Şafak Yılmaz BARAN
(Başkent Üniversitesi, Tıp Fakültesi Kadın Hastalıkları ve Doğum Ana Bilim Dalı, Adana Uygulama ve Araştırma Hastanesi, Adana, Türkiye)
Seda Yüksel ŞİMŞEK
(Başkent Üniversitesi, Tıp Fakültesi Kadın Hastalıkları ve Doğum Ana Bilim Dalı, Adana Uygulama ve Araştırma Hastanesi, Adana, Türkiye)
Songül ALEMDAROĞLU
(Başkent Üniversitesi, Tıp Fakültesi Kadın Hastalıkları ve Doğum Ana Bilim Dalı, Adana Uygulama ve Araştırma Hastanesi, Adana, Türkiye)
Serdinç ÖZDOĞAN
(Başkent Üniversitesi, Tıp Fakültesi Kadın Hastalıkları ve Doğum Ana Bilim Dalı, Adana Uygulama ve Araştırma Hastanesi, Adana, Türkiye)
Esra Bulgan KILIÇDAĞ
(Başkent Üniversitesi, Tıp Fakültesi Kadın Hastalıkları ve Doğum Ana Bilim Dalı, Adana Uygulama ve Araştırma Hastanesi, Adana, Türkiye)
Yıl: 2020Cilt: 21Sayı: 2ISSN: 1309-0399 / 1309-0380Sayfa Aralığı: 97 - 101İngilizce

111 0
Pregnancy of patients with idiopathic thrombocytopenic purpura: maternal and neonatal outcomes
Objective: Thrombocytopenia occurs in 7% of pregnant women. Along with other causes, idiopathic thrombocytopenic purpura (ITP), which isan autoimmune disease with autoantibodies causing platelet destruction, must be considered in the differential diagnosis. Antiplatelet antibodiescan cross the placenta and cause thrombocytopenia in the newborn. The aim of our study was to assess the management of ITP in pregnancy,and to investigate neonatal outcomes.Material and Methods: This retrospective study was conducted in a tertiary center including 89 pregnant patients with ITP followed betweenOctober 2011 and January 2018. Patients were evaluated in two groups according to diagnoses of ITP and chronic ITP. Age, obstetric history, ITPdiagnosis, and follow-up period, presence of splenectomy, platelet count during pregnancy and after birth, treatment during pregnancy, route ofdelivery, weight and platelet count of newborn, sign of hemorrhage, and fetal congenital anomaly were assessed.Results: Considering the ITP and chronic ITP groups, no significant difference was seen with respect to parity, timing of delivery, preoperativeand postoperative platelet counts, and hemoglobin values. Route of delivery, birth weight, APGAR scores, newborn platelet count, and congenitalanomaly rates were also similar. The timing of treatment was different because patients whose diagnoses were established during pregnancywere mostly treated for preparation of delivery. Treatment modalities were similar.Conclusion: Probability of severe thrombocytopenia at delivery is higher in patients with ITP who are diagnosed during pregnancy whencompared with patients who received prepregnancy diagnoses. ITP is an important disease for both the mother and newborn. Patients shouldbe followed closely in cooperation with the hematology department. (J Turk Ger Gynecol Assoc 2020; 21: 97-101)
DergiAraştırma MakalesiErişime Açık
  • 1. Wyszynski DF, Carman WJ, Cantor AB, Graham Jr JM, Kunz LH, Slavotinek AM, et al. Pregnancy and birth outcomes among women with idiopathic thrombocytopenic purpura. J Pregnancy 2016;2016:8297407.
  • 2. Subbaiah M, Kumar S, Roy KK, Sharma JB, Singh N. Pregnancy outcome in patients with idiopathic thrombocytopenic purpura. Arch Gynecol Obstet 2014; 289, 269-73.
  • 3. Wang X, Xu Y, Luo W, Feng H, Luo Y, Wang Y, et al. Thrombocytopenia in pregnancy with different diagnoses. Differential clinical features, treatments, and outcomes. Medicine 2017; 96: e7561.
  • 4. Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood 2013; 121: 38-47.
  • 5. Yuce T, Acar D, Kalafat E, Alkilic A, Cetindag E, Soylemez F. Thrombocytopenia in pregnancy: do the time of diagnosis and delivery route affect pregnancy outcome in parturients with idiopathic thrombocytopenic purpura? Int J Hematol 2014; 100: 540-4.
  • 6. Won YW, Moon W, Yun YS, Oh HS, Choi JH, Lee YY, et al. Clinical aspects of pregnancy and delivery in patients with chronic idiopathic thrombocytopenic purpura (ITP). Korean J Intern Med 2005; 20: 129-34.
  • 7. Sun D, Shehata N, Ye XY, Gregorovich S, De France B, Arnold DM, et al. Corticosteroids compared with intravenous immunoglobulin fort he treatment of immune thrombocytopenia in pregnancy. Blood 2016; 128: 1329-35.
  • 8. Inocêncio G, Coutinho L, Buchner G, Zulmira R. Idiopathic thrombocytopenic purpura during pregnancy. BMJ Case Rep 2013.
  • 9. Lee LO, Bateman BT, Kheterpal S, Klumpner TT, Housey M, Aziz MF, et al. Risk of Epidural Hematoma After Neuraxial Techniques in Thrombocytopenic Parturients: A Report from the Multicenter Perioperative Outcomes Group. Anesthesiology 2017; 126: 1053-64.
  • 10. Fujimura K, Harada Y, Fujimoto T, Kuramoto A, Ikeda Y, Akatsuka J, et al. Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol 2002; 75: 426-33.
  • 11. Loustau V, Debouverie O, Canoui-Poi-trine F, Baili L, Khellaf M, Touboul C, et al. Effects of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women. Br J Haematol 2014; 166: 929-35.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.